Publications by authors named "M A M Lemmens"

Photon-counting detector computed tomography (PCD-CT) has emerged as a revolutionary technology in CT imaging. PCD-CT offers significant advancements over conventional energy-integrating detector CT, including increased spatial resolution, artefact reduction and inherent spectral imaging capabilities. In cardiac imaging, PCD-CT can offer a more accurate assessment of coronary artery disease, plaque characterisation and the in-stent lumen.

View Article and Find Full Text PDF
Article Synopsis
  • Colonoscopy surveillance for colorectal cancer (CRC) can be burdensome for patients, and stool tests might help reduce the need for colonoscopies by identifying individuals at higher risk.
  • This study involved 3453 participants aged 50-75 who completed multiple stool tests and colonoscopies to assess the accuracy of these methods for detecting advanced neoplasia.
  • Results indicated that stool-based strategies could effectively reduce colonoscopy frequency by 15%-41% while being safer and more cost-effective, particularly with fecal immunochemical tests (FITs), although multitarget stool DNA testing was found to be more expensive.
View Article and Find Full Text PDF
Article Synopsis
  • Colonoscopy surveillance for individuals with Lynch syndrome is challenging, and colorectal cancers can still occur despite regular screenings.
  • A study evaluated the efficacy of fecal immunochemical tests (FIT) to determine the best intervals for colonoscopy by measuring specific thresholds of hemoglobin in stool samples.
  • Results indicated that using a lower FIT threshold (2.5 μg Hb/g) increased the detection rate of relevant neoplasia, with even better specificity seen at a threshold of 4.1 μg Hb/g, suggesting that FIT could potentially allow many Lynch syndrome patients to delay unnecessary colonoscopies while still effectively identifying those at risk for advanced neoplasia.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on the safety concerns of residual undifferentiated pluripotent stem cells (PSCs) in cell therapy products (CTPs), which could lead to tumor formation in clinical applications.
  • - Researchers tested a droplet digital PCR (ddPCR) method to detect leftover induced pluripotent stem cells (iPSCs) in cardiomyocyte samples by varying their concentrations and measuring specific iPSC markers for accuracy.
  • - Findings indicated that the RT-ddPCR assay effectively identifies iPSC impurities in CTPs, with variability primarily arising from how iPSCs were added to samples, showcasing the method's potential for ensuring safety in PSC-derived therapies.
View Article and Find Full Text PDF